174 related articles for article (PubMed ID: 23595591)
1. Calretinin is essential for mesothelioma cell growth/survival in vitro: a potential new target for malignant mesothelioma therapy?
Blum W; Schwaller B
Int J Cancer; 2013 Nov; 133(9):2077-88. PubMed ID: 23595591
[TBL] [Abstract][Full Text] [Related]
2. A cytokeratin- and calretinin-negative staining sarcomatoid malignant mesothelioma.
Hurtuk MG; Carbone M
Anticancer Res; 2004; 24(5B):3097-102. PubMed ID: 15510595
[TBL] [Abstract][Full Text] [Related]
3. Calretinin Functions in Malignant Mesothelioma Cells Cannot Be Replaced by the Closely Related Ca
Wörthmüller J; Oberson A; Salicio V; Blum W; Schwaller B
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30545133
[TBL] [Abstract][Full Text] [Related]
4. SV40-induced expression of calretinin protects mesothelial cells from asbestos cytotoxicity and may be a key factor contributing to mesothelioma pathogenesis.
Henzi T; Blum WV; Pfefferli M; Kawecki TJ; Salicio V; Schwaller B
Am J Pathol; 2009 Jun; 174(6):2324-36. PubMed ID: 19435792
[TBL] [Abstract][Full Text] [Related]
5. Primary thymic epithelial tumours of the pleura mimicking malignant mesothelioma.
Attanoos RL; Galateau-Salle F; Gibbs AR; Muller S; Ghandour F; Dojcinov SD
Histopathology; 2002 Jul; 41(1):42-9. PubMed ID: 12121236
[TBL] [Abstract][Full Text] [Related]
6. D2-40 and calretinin - a tissue microarray analysis of 341 malignant mesotheliomas with emphasis on sarcomatoid differentiation.
Hinterberger M; Reineke T; Storz M; Weder W; Vogt P; Moch H
Mod Pathol; 2007 Feb; 20(2):248-55. PubMed ID: 17361207
[TBL] [Abstract][Full Text] [Related]
7. Temsirolimus inhibits malignant pleural mesothelioma growth in vitro and in vivo: synergism with chemotherapy.
Hoda MA; Mohamed A; Ghanim B; Filipits M; Hegedus B; Tamura M; Berta J; Kubista B; Dome B; Grusch M; Setinek U; Micksche M; Klepetko W; Berger W
J Thorac Oncol; 2011 May; 6(5):852-63. PubMed ID: 21358348
[TBL] [Abstract][Full Text] [Related]
8. A₃ receptors are overexpressed in pleura from patients with mesothelioma and reduce cell growth via Akt/nuclear factor-κB pathway.
Varani K; Maniero S; Vincenzi F; Targa M; Stefanelli A; Maniscalco P; Martini F; Tognon M; Borea PA
Am J Respir Crit Care Med; 2011 Feb; 183(4):522-30. PubMed ID: 20870754
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological targeting of p53 through RITA is an effective antitumoral strategy for malignant pleural mesothelioma.
Di Marzo D; Forte IM; Indovina P; Di Gennaro E; Rizzo V; Giorgi F; Mattioli E; Iannuzzi CA; Budillon A; Giordano A; Pentimalli F
Cell Cycle; 2014; 13(4):652-65. PubMed ID: 24345738
[TBL] [Abstract][Full Text] [Related]
10. Overexpression or absence of calretinin in mouse primary mesothelial cells inversely affects proliferation and cell migration.
Blum W; Pecze L; Felley-Bosco E; Schwaller B
Respir Res; 2015 Dec; 16():153. PubMed ID: 26695618
[TBL] [Abstract][Full Text] [Related]
11. AHNAK is highly expressed and plays a key role in cell migration and invasion in mesothelioma.
Sudo H; Tsuji AB; Sugyo A; Abe M; Hino O; Saga T
Int J Oncol; 2014 Feb; 44(2):530-8. PubMed ID: 24253341
[TBL] [Abstract][Full Text] [Related]
12. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
Szczepulska-Wójcik E; Langfort R; Roszkowski-Sliz K
Pneumonol Alergol Pol; 2007; 75(1):57-69. PubMed ID: 17541913
[TBL] [Abstract][Full Text] [Related]
13. Combined treatment with cisplatin and sirolimus to enhance cell death in human mesothelioma.
Hartman ML; Esposito JM; Yeap BY; Sugarbaker DJ
J Thorac Cardiovasc Surg; 2010 May; 139(5):1233-40. PubMed ID: 19853261
[TBL] [Abstract][Full Text] [Related]
14. Calretinin promotes invasiveness and EMT in malignant mesothelioma cells involving the activation of the FAK signaling pathway.
Wörthmüller J; Blum W; Pecze L; Salicio V; Schwaller B
Oncotarget; 2018 Nov; 9(91):36256-36272. PubMed ID: 30555628
[TBL] [Abstract][Full Text] [Related]
15. New pyrazolo[3,4-d]pyrimidine SRC inhibitors induce apoptosis in mesothelioma cell lines through p27 nuclear stabilization.
Indovina P; Giorgi F; Rizzo V; Khadang B; Schenone S; Di Marzo D; Forte IM; Tomei V; Mattioli E; D'Urso V; Grilli B; Botta M; Giordano A; Pentimalli F
Oncogene; 2012 Feb; 31(7):929-38. PubMed ID: 21785466
[TBL] [Abstract][Full Text] [Related]
16. EF24 and RAD001 potentiates the anticancer effect of platinum-based agents in human malignant pleural mesothelioma (MSTO-211H) cells and protects nonmalignant mesothelial (MET-5A) cells.
Onen HI; Yilmaz A; Alp E; Celik A; Demiroz SM; Konac E; Kurul IC; Menevse ES
Hum Exp Toxicol; 2015 Feb; 34(2):117-26. PubMed ID: 25028262
[TBL] [Abstract][Full Text] [Related]
17. Anti-mesothelial markers in sarcomatoid mesothelioma and other spindle cell neoplasms.
Attanoos RL; Dojcinov SD; Webb R; Gibbs AR
Histopathology; 2000 Sep; 37(3):224-31. PubMed ID: 10971698
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma.
Jänne PA; Taffaro ML; Salgia R; Johnson BE
Cancer Res; 2002 Sep; 62(18):5242-7. PubMed ID: 12234991
[TBL] [Abstract][Full Text] [Related]
19. Malignant pleural mesothelioma cells resist anoikis as quiescent pluricellular aggregates.
Daubriac J; Fleury-Feith J; Kheuang L; Galipon J; Saint-Albin A; Renier A; Giovannini M; Galateau-Sallé F; Jaurand MC
Cell Death Differ; 2009 Aug; 16(8):1146-55. PubMed ID: 19343038
[TBL] [Abstract][Full Text] [Related]
20. Combinatorial anti-angiogenic gene therapy in a human malignant mesothelioma model.
Kubo S; Takagi-Kimura M; Kasahara N
Oncol Rep; 2015 Aug; 34(2):633-8. PubMed ID: 26082103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
